Biogen Inc. is 10% Owner at SANGAMO THERAPEUTICS, INC (SGMO). They have made 6 open-market trades across 1 company since 2021, most recently 2023-09-26.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGMO | 17,652,466 | $3.1M |
Shares reported on the most recent Form 4, priced at the 2023-09-28 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 100% | 100% |
| Avg Move | -4.0% | -17.7% | -24.5% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGMO | SELL | 2023-09-26 | 2023-09-28 | $0.50 | $3.0M | -8.7% | -12.2% | -10.5% |
| SGMO | SELL | 2022-08-29 | 2022-08-31 | $5.32 | $2.7M | +2.4% | -8.1% | -33.6% |
| SGMO | SELL | 2021-12-28 | 2021-12-30 | $8.51 | $24K | -13.1% | -22.5% | -23.8% |
| SGMO | SELL | 2021-12-23 | 2021-12-28 | $8.55 | $1.4M | -15.5% | -31.1% | -28.5% |
| SGMO | SELL | 2021-12-09 | 2021-12-10 | $8.56 | $405K | +7.7% | -14.7% | -24.7% |
| SGMO | SELL | 2021-12-07 | 2021-12-09 | $8.59 | $2.2M | +3.1% | -17.4% | -26.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.